Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluates topical tranexamic acid to reduce intraoperative blood loss during cesarean delivery; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranexamic acid (topical) (tranexamic acid)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Cesarean Delivery, Postpartum Hemorrhage (PPH) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING